HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG Petition Denied By FDA; Group Seeks Dialogue With CTFA

This article was originally published in The Rose Sheet

Executive Summary

Sufficient data were not provided by the Environmental Working Group in its 2004 citizen petition for FDA to evaluate the safety of certain cosmetic ingredients, the agency maintains. FDA's Center for Food Safety & Applied Nutrition issued a denial of the petition, which sought removal of beauty products containing allegedly unsafe substances from the market, in a recent letter to the advocacy group

You may also be interested in...



FDA Surveys Cosmetic Products For Asbestos-Contaminated Talc

FDA is reviewing talc and talc-containing cosmetic products for asbestos contamination following reports of the carcinogen in cosmetics overseas

FDA Surveys Cosmetic Products For Asbestos-Contaminated Talc

FDA is reviewing talc and talc-containing cosmetic products for asbestos contamination following reports of the carcinogen in cosmetics overseas

FDA Surveying U.S. Cosmetic Products For Asbestos-Contaminated Talc

FDA is reviewing talc and talc-containing cosmetic products on the U.S. market for asbestos contamination following reports of the carcinogen in cosmetics overseas, according to an FDA spokesman

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel